Ftse Mib
32.908,05
0,74%
DAX
18.068,21
0,26%
S&P 500
5.473,23
0,77%
NASDAQ
17.857,02
0,95%
Bitcoin
65.412,55
-1,61%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Telesis Bio Inc (TBIO) Telesis Bio Inc (TBIO) Notizie

Telesis Bio Inc

TBIO
3,9082
-1,08 (-21,68%)
18 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
12/6/202423:00EDGAR2Form 8-K - Current report
11/6/202402:40EDGAR2Form SC 13D/A - General statement of acquisition of..
11/6/202402:30EDGAR2Form SC 13D/A - General statement of acquisition of..
10/5/202412:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:15EDGAR2Form 8-K - Current report
09/5/202422:05GLOBETelesis Bio Reports First Quarter 2024 Financial Results
06/5/202422:30EDGAR2Form 8-K - Current report
06/5/202422:05GLOBETelesis Bio Announces Reverse Stock Split
18/4/202415:00GLOBETelesis Bio Inc. announces strategic focus on game-changing..
28/3/202421:05GLOBETelesis Bio Reports Fourth Quarter and Full Year 2023..
06/3/202400:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202400:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202400:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202402:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202402:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202423:00EDGAR2Form 8-K - Current report
26/2/202415:15GLOBETelesis Bio Announces Select Preliminary Fourth Quarter..
30/11/202323:00EDGAR2Form 8-K - Current report
13/11/202322:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:32EDGAR2Form 8-K - Current report
13/11/202322:22GLOBETelesis Bio Reports Third Quarter 2023 Financial Results
09/11/202323:00EDGAR2Form 8-K - Current report
07/11/202315:00GLOBETelesis Bio to Report Third Quarter Financial Results on..
03/11/202317:00GLOBETelesis Bio Announces Commercial Release of Cell-free..
24/10/202322:30EDGAR2Form 8-K - Current report
28/9/202321:48GLOBETelesis Bio Announces Commercial Release of BioXp® NGS..
22/9/202323:00EDGAR2Form 8-K - Current report
29/8/202322:05GLOBETelesis Bio Appoints William J. Kullback Chief Financial..
29/8/202322:02EDGAR2Form 8-K - Current report
11/8/202312:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:17EDGAR2Form 8-K - Current report
10/8/202322:05GLOBETelesis Bio Reports Second Quarter 2023 Financial Results
04/8/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
03/8/202323:00GLOBETelesis Bio to Report Second Quarter Financial Results on..
27/7/202323:28EDGAR2Form S-3 - Registration statement under Securities Act of..
07/7/202322:01EDGAR2Form 8-K - Current report
Apertura: 5,38 Min: 3,45 Max: 5,40
Chiusura: 4,99

La tua Cronologia

NASDAQ
TBIO
Telesis Bio
LSE
NSCI
Netscientific
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network